Nanoscale X-Ray Technique Devised for Imaging of Bacterial Cells
|
By LabMedica International staff writers Posted on 19 Jan 2010 |
An ultra-high resolution imaging technique using X-ray diffraction is one step closer to fulfilling its potential as a window into nanometer-scale structures in biologic samples.
In research published December 17, 2009, in the online issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS), researchers reported progress in applying an approach to "lensless” X-ray microscopy, which they introduced one year ago. They have produced the first images, using this technique, of biologic cells--specifically the fascinating polyextremophile Deinococcus radiodurans.
Improved ability to see nanoscale structures in cells could provide significant insights for evolutionary biology and biotechnology. In the case of D. radiodurans, for example, it could help to answer questions about whether--or how--the structure of this organism's DNA-bearing nucleoid region accounts for its stamina against ionizing radiation. Having demonstrated the resolution, effectiveness, and reproducibility of their technique, the researchers are now working to extend it to three-dimensional (3D) imaging of biologic cells.
X-ray imaging is best known for its medical applications, such as conventional radiographs and computed tomography (CT) scans. However, the use of X-rays goes far beyond standard imaging. In particular, the very short wavelength of X-ray radiation allows various modes of microscopy that can reach the nanometer resolution. One of the major obstacles to high-resolution X-ray microscopy is the difficulty of producing high-quality X-ray lenses. To overcome these difficulties, so-called lensless microscopy methods have emerged in the last decade. A technique developed by researchers now in the biomedical physics group from the Technische Universitaet Muenchen (TUM; Munich. Germany) has shown great promise for ultra-high resolution imaging of materials and life science samples.
This imaging technique, called ptychography, was first introduced in the 1970s for electron diffraction. It consists in measuring full far-field diffraction patterns as a small illumination is scanned on a sample. While its use in electron microscopy is still limited, ptychography has gained tremendous popularity in the X-ray imaging community in the last few years, due to the development by Franz Pfeiffer, now chair of the biomedical physics group at TUM, and his team. A critical step in the development of ptychography was published by the team one year ago and published in the August 15, 2009, issue of the journal Science. The super-resolution capability of the imaging method was successfully demonstrated with a gold test structure.
Now a collaboration of the Pfeiffer group, together with researchers from the University of Gottingen (Germany) and at the Swiss Light Source (Villigen, Switzerland), has gone a step further and produced the first images of biologic cells with the same technique.
These study findings demonstrated that lensless X-ray imaging, specifically ptychography, could be used to obtain precise maps of the electron density forming a biologic sample. This type of quantitative measurement is extremely difficult with most other high-resolution techniques currently available. Moreover, biologic samples are very fragile and nearly transparent to X-rays, making this type of accurate measurement even more challenging.
The Pfeiffer group is now moving beyond this achievement and looking into ways of additionally improving the technique. In particular, the team is aiming at the next milestone: 3D imaging of biologic samples.
Related Links:
Technische Universitaet Muenchen
University of Gottingen
In research published December 17, 2009, in the online issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS), researchers reported progress in applying an approach to "lensless” X-ray microscopy, which they introduced one year ago. They have produced the first images, using this technique, of biologic cells--specifically the fascinating polyextremophile Deinococcus radiodurans.
Improved ability to see nanoscale structures in cells could provide significant insights for evolutionary biology and biotechnology. In the case of D. radiodurans, for example, it could help to answer questions about whether--or how--the structure of this organism's DNA-bearing nucleoid region accounts for its stamina against ionizing radiation. Having demonstrated the resolution, effectiveness, and reproducibility of their technique, the researchers are now working to extend it to three-dimensional (3D) imaging of biologic cells.
X-ray imaging is best known for its medical applications, such as conventional radiographs and computed tomography (CT) scans. However, the use of X-rays goes far beyond standard imaging. In particular, the very short wavelength of X-ray radiation allows various modes of microscopy that can reach the nanometer resolution. One of the major obstacles to high-resolution X-ray microscopy is the difficulty of producing high-quality X-ray lenses. To overcome these difficulties, so-called lensless microscopy methods have emerged in the last decade. A technique developed by researchers now in the biomedical physics group from the Technische Universitaet Muenchen (TUM; Munich. Germany) has shown great promise for ultra-high resolution imaging of materials and life science samples.
This imaging technique, called ptychography, was first introduced in the 1970s for electron diffraction. It consists in measuring full far-field diffraction patterns as a small illumination is scanned on a sample. While its use in electron microscopy is still limited, ptychography has gained tremendous popularity in the X-ray imaging community in the last few years, due to the development by Franz Pfeiffer, now chair of the biomedical physics group at TUM, and his team. A critical step in the development of ptychography was published by the team one year ago and published in the August 15, 2009, issue of the journal Science. The super-resolution capability of the imaging method was successfully demonstrated with a gold test structure.
Now a collaboration of the Pfeiffer group, together with researchers from the University of Gottingen (Germany) and at the Swiss Light Source (Villigen, Switzerland), has gone a step further and produced the first images of biologic cells with the same technique.
These study findings demonstrated that lensless X-ray imaging, specifically ptychography, could be used to obtain precise maps of the electron density forming a biologic sample. This type of quantitative measurement is extremely difficult with most other high-resolution techniques currently available. Moreover, biologic samples are very fragile and nearly transparent to X-rays, making this type of accurate measurement even more challenging.
The Pfeiffer group is now moving beyond this achievement and looking into ways of additionally improving the technique. In particular, the team is aiming at the next milestone: 3D imaging of biologic samples.
Related Links:
Technische Universitaet Muenchen
University of Gottingen
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








